APO C300 (Carbamazepine extended-release 300 mg)
Pill imprint APO C300 has been identified as Carbamazepine extended-release 300 mg.
Carbamazepine is used in the treatment of trigeminal neuralgia; bipolar disorder; schizoaffective disorder; epilepsy; borderline personality disorder (and more), and belongs to the drug class dibenzazepine anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Carbamazepine 300 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- APO C300
- Strength:
- 300 mg
- Color:
- White / Green
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Dibenzazepine anticonvulsants
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Apotex Corp.
More about carbamazepine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 231 Reviews – Add your own review/rating
- Drug class: dibenzazepine anticonvulsants
Consumer resources
- Carbamazepine
- Carbamazepine chewable tablets
- Carbamazepine suspension
- Carbamazepine sustained-release capsules
- Carbamazepine sustained-release tablets
- More... (2)
Other brands: Tegretol, Carbatrol, Epitol, Tegretol XR, More... (2)
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
